AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8522408 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 6.25 mg orally 15 min before thrombolysis
Number of subjects: 73
Study 8522408 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 2678209 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Potential for Hostility (dichotomized into 'low' and 'high')
Number of subjects: 576
Study 2678209 — intervention group
Group type: EXPERIMENTAL
Intervention: Stylistic Hostility (antagonistic interpersonal component of hostility)
Number of subjects: 576
Study 2678209 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichotomous Potential for Hostility (after adjustment for traditional risk factors)
Number of subjects: 576
Study 2678209 — intervention group
Group type: COMPARATOR
Intervention: Global TABP and related paralinguistic attributes
Number of subjects: 576
Study 7258828 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal obstruction
Number of subjects: 10
Study 30361740 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis (AFO)
Number of subjects: 26
Study 28043754 — intervention group
Group type: EXPERIMENTAL
Intervention: High medication adherence
Number of subjects: 92
Study 27532914 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral protection device (filter group)
Number of subjects: 100
Study 27532914 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cerebral protection device)
Number of subjects: 100
Study 24976394 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (to 600 mg/d)
Number of subjects: 90
Study 24976394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 24976394 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 90
Study 22950430 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy with 1 mg of estradiol hemihydrate (1 mg/day) orally for 6 months
Number of subjects: 60
Study 22950430 — intervention group
Group type: COMPARATOR
Intervention: Not taking estrogen (control group)
Number of subjects: 60
Study 20472123 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient information digital video disk (DVD)
Number of subjects: 106
Study 18719013 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined hormone replacement therapy (HRT) - Conjugated equine oestrogen 0.625 mg plus medroxyprogesterone acetate 2.5/5.0 mg orally daily for one year
Number of subjects: 3721
Study 18719013 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3721
Study 15955017 — intervention group
Group type: EXPERIMENTAL
Intervention: Reimbursement for nicotine replacement therapy, bupropion and behavioural counselling (intervention group)
Number of subjects: 1266
Study 15955017 — intervention group
Group type: COMPARATOR
Intervention: No reimbursement (control group)
Number of subjects: 1266
Study 12550815 — intervention group
Group type: EXPERIMENTAL
Intervention: Velocity dependent passive plantarflexor resistive torque in adults with brain injury
Number of subjects: 28
Study 12550815 — intervention group
Group type: COMPARATOR
Intervention: Velocity dependent passive plantarflexor resistive torque in age-matched controls
Number of subjects: 28
Study 10352773 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilute epinephrine saline irrigation (1 mg/l)
Number of subjects: 105
Study 10352773 — intervention group
Group type: COMPARATOR
Intervention: Normal saline irrigation (placebo)
Number of subjects: 105
Study 7837863 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumcised group (after DPT)
Number of subjects: 60
Study 7837863 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumcised group (after HIB)
Number of subjects: 60
Study 1646290 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg sumatriptan
Number of subjects: 1130
Study 1646290 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg sumatriptan
Number of subjects: 1130
Study 1646290 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg sumatriptan
Number of subjects: 1130
Study 1646290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1130
Study 6409496 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin
Number of subjects: 60
Study 6409496 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual nitroglycerin
Number of subjects: 60
Study 30904852 — intervention group
Group type: EXPERIMENTAL
Intervention: Diluted epinephrine
Number of subjects: 0
Study 30904852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28399154 — intervention group
Group type: EXPERIMENTAL
Intervention: Silk garments plus standard care
Number of subjects: 300
Study 28399154 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 300
Study 26941454 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based breastfeeding intervention delivered by lactation educators
Number of subjects: 298
Study 26941454 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 298
Study 23912778 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laser group (n = 20)
Number of subjects: 40
Study 23912778 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser group (n = 20)
Number of subjects: 40
Study 23009302 — intervention group
Group type: EXPERIMENTAL
Intervention: Managed controlled-opioid prescription monitoring program
Number of subjects: 0
Study 23009302 — intervention group
Group type: COMPARATOR
Intervention: General information letter notifying prescribers of available managed care resources
Number of subjects: 0
Study 19952244 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (118 patients) completed self-report questionnaires at four weeks preoperatively, on the day of surgery, and at six weeks and three months postoperatively.
Number of subjects: 174
Study 19952244 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (56 patients) completed self-report questionnaires at six weeks and three months postoperatively.
Number of subjects: 174
Study 18175829 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol 400 microg
Number of subjects: 349
Study 18175829 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 349
Study 15053909 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-rinsing conditioner (NRC) solely in superficial dentin (SD)
Number of subjects: 18
Study 15053909 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser (80 mJ/2 Hz) + NRC in superficial dentin (SD)
Number of subjects: 18
Study 15053909 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser solely in superficial dentin (SD)
Number of subjects: 18
Study 15053909 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-rinsing conditioner (NRC) solely in deep dentin (DD)
Number of subjects: 18
Study 15053909 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser (80 mJ/2 Hz) + NRC in deep dentin (DD)
Number of subjects: 18
Study 15053909 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser solely in deep dentin (DD)
Number of subjects: 18
Study 11230838 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day (n = 730)
Number of subjects: 1424
Study 11230838 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 10 mg/day (n = 694)
Number of subjects: 1424
Study 9604107 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-coated stems
Number of subjects: 79
Study 9604107 — intervention group
Group type: COMPARATOR
Intervention: Smooth stems
Number of subjects: 79
Study 9604107 — intervention group
Group type: EXPERIMENTAL
Intervention: Porous-coated stems
Number of subjects: 79
Study 8067763 — intervention group
Group type: EXPERIMENTAL
Intervention: Foscarnet (maintenance therapy)
Number of subjects: 9
Study 3055923 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (20 mg twice daily)
Number of subjects: 16
Study 3055923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31811995 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 959
Study 31811995 — intervention group
Group type: COMPARATOR
Intervention: Lower levels of adiponectin and higher levels of resistin
Number of subjects: 959
Study 29600816 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 per cent chlorhexidine with 70 per cent isopropanol (CA)
Number of subjects: 500
Study 29600816 — intervention group
Group type: COMPARATOR
Intervention: 70 per cent isopropanol (PA)
Number of subjects: 500
Study 28126707 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant therapy
Number of subjects: 101
Study 28126707 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses' recommendations to intensify treatment
Number of subjects: 101
Study 28126707 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendations to start treatment
Number of subjects: 101
Study 28126707 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal providers' willingness to provide treatment
Number of subjects: 101
Study 26218871 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX)
Number of subjects: 43
Study 26218871 — intervention group
Group type: EXPERIMENTAL
Intervention: Osmotic Release Oral System-Methylphenidate (OROS-MPH)
Number of subjects: 43
Study 23277482 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin-S-1
Number of subjects: 564
Study 23277482 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin-paclitaxel
Number of subjects: 564
Study 23277482 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin-S-1 (SCC subgroup)
Number of subjects: 564
Study 23277482 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin-paclitaxel (SCC subgroup)
Number of subjects: 564
Study 23277482 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin-S-1 (non-SCC subgroup)
Number of subjects: 564
Study 23277482 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin-paclitaxel (non-SCC subgroup)
Number of subjects: 564
Study 22007892 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-like TENS (AL-TENS)
Number of subjects: 43
Study 22007892 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional TENS
Number of subjects: 43
Study 22007892 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 43
Study 19061291 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 section examined
Number of subjects: 53
Study 19061291 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 sections examined
Number of subjects: 53
Study 19061291 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 sections examined
Number of subjects: 53
Study 19061291 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 sections examined
Number of subjects: 53
Study 19061291 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 section examined for atherosis
Number of subjects: 53
Study 19061291 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 sections examined for atherosis
Number of subjects: 53
Study 19061291 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 sections examined for atherosis
Number of subjects: 53
Study 19061291 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 sections examined for atherosis
Number of subjects: 53
Study 15716289 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse led clinics to promote medical and lifestyle components of secondary prevention
Number of subjects: 1343
Study 15716289 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1343
Study 12911180 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed saline irrigation
Number of subjects: 38
Study 12911180 — intervention group
Group type: COMPARATOR
Intervention: Room temperature saline irrigation
Number of subjects: 38
Study 10555127 — intervention group
Group type: EXPERIMENTAL
Intervention: Topotecan (dl-5) and cytarabine (1 g/m2 over 2 hours; dl-5)
Number of subjects: 37
Study 10555127 — intervention group
Group type: EXPERIMENTAL
Intervention: Topotecan (d1-5) followed by etoposide (250 mg/m2 twice daily, d6-7)
Number of subjects: 37
Study 10555127 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide (250 mg/m2 twice daily dl-2) followed by topotecan (d3-d7)
Number of subjects: 37
Study 8670317 — intervention group
Group type: EXPERIMENTAL
Intervention: anti-CD5 ricin-linked immunoconjugate (CD5-IC) at doses up to 8 mg/m2/day for 4 days in 1 month
Number of subjects: 104
Study 8670317 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 1804789 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 137
Study 1804789 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP/SMX)
Number of subjects: 137
Study 6833194 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 22
Study 6833194 — intervention group
Group type: COMPARATOR
Intervention: Tranylcypromine
Number of subjects: 22
Study 30426791 — intervention group
Group type: EXPERIMENTAL
Intervention: Resurfacing hip arthroplasty (RHA)
Number of subjects: 82
Study 30426791 — intervention group
Group type: COMPARATOR
Intervention: Total hip arthroplasty (THA)
Number of subjects: 82
Study 30016328 — intervention group
Group type: EXPERIMENTAL
Intervention: IPTp-DP every 4 weeks (DP4w)
Number of subjects: 291
Study 30016328 — intervention group
Group type: EXPERIMENTAL
Intervention: IPTp-DP every 8 weeks (DP8w)
Number of subjects: 291
Study 30016328 — intervention group
Group type: COMPARATOR
Intervention: IPTp-SP every 8 weeks (SP8w)
Number of subjects: 291
Study 27347650 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced adherence counseling intervention delivered by nurses from a central call site
Number of subjects: 59
Study 24810539 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient specific instrumentation (PSI)
Number of subjects: 60
Study 24810539 — intervention group
Group type: COMPARATOR
Intervention: Computer-assisted surgery (CAS)
Number of subjects: 60
Study 23171383 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive resilience intervention implemented in intervention schools.
Number of subjects: 32
Study 23171383 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 32
Study 19910627 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine (2.5 mg)
Number of subjects: 228
Study 19910627 — intervention group
Group type: COMPARATOR
Intervention: Epidural saline (placebo)
Number of subjects: 228
Study 17503979 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 20
Study 17503979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 12675121 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (n = 32)
Number of subjects: 62
Study 12675121 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 33)
Number of subjects: 62
Study 11094007 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine and clonidine combination
Number of subjects: 15
Study 11094007 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal morphine alone
Number of subjects: 15
Study 11094007 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal clonidine alone
Number of subjects: 15
Study 11094007 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 8880835 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid antagonist naltrexone (low dose)
Number of subjects: 45
Study 8880835 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 8880835 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid antagonist naltrexone (high dose)
Number of subjects: 45
Study 1544959 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented knee arthroplasty
Number of subjects: 29
Study 1544959 — intervention group
Group type: COMPARATOR
Intervention: Uncemented knee arthroplasty
Number of subjects: 29
Study 3885984 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg domperidone
Number of subjects: 60
Study 3885984 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg metoclopramide
Number of subjects: 60
Study 3885984 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 60
Study 31855906 — intervention group
Group type: EXPERIMENTAL
Intervention: PNs associated with HA (PNHA)
Number of subjects: 100
Study 31855906 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic Acid (HA) alone
Number of subjects: 100
Study 28886992 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 98
Study 28886992 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 98
Study 26123410 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobutrol
Number of subjects: 74
Study 26123410 — intervention group
Group type: COMPARATOR
Intervention: Gadoterate meglumine
Number of subjects: 74
Study 24375207 — intervention group
Group type: EXPERIMENTAL
Intervention: Perphenazine
Number of subjects: 1049
Study 22223569 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasta with normal wheat bran (PA)
Number of subjects: 10
Study 22223569 — intervention group
Group type: COMPARATOR
Intervention: Bread with normal wheat bran (CB)
Number of subjects: 10
Study 22223569 — intervention group
Group type: COMPARATOR
Intervention: Bread with purple wheat bran (PBB)
Number of subjects: 10
Study 19955827 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol added to antihypertensive treatment
Number of subjects: 33
Study 19955827 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 33
Study 19955827 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 33
Study 19955827 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 33
Study 18818173 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (n=100) - integrated intervention program including diabetes education, frequent blood glucose monitoring, nutritional counseling, meal plans with diabetes-specific nutritional meal replacement, and weekly progress updates
Number of subjects: 150
Study 18818173 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (n=100)
Number of subjects: 150
Study 18818173 — intervention group
Group type: COMPARATOR
Intervention: Reference Group (n=50) - received diabetes education including diet and physical activity instruction only
Number of subjects: 150
Study 15801247 — intervention group
Group type: EXPERIMENTAL
Intervention: Diary cards
Number of subjects: 157
Study 15801247 — intervention group
Group type: COMPARATOR
Intervention: Electronic monitoring
Number of subjects: 157
Study 12444889 — intervention group
Group type: EXPERIMENTAL
Intervention: ATD combined with l‐thyroxine (l‐T(4))
Number of subjects: 218
Study 12444889 — intervention group
Group type: EXPERIMENTAL
Intervention: ATD alone
Number of subjects: 218
Study 12444889 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 218
Study 12444889 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAb positive after 12 Months of antithyroid therapy
Number of subjects: 218
Study 12444889 — intervention group
Group type: EXPERIMENTAL
Intervention: Large goiter
Number of subjects: 218
Study 10551685 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic administration
Number of subjects: 2195
Study 10551685 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent placement
Number of subjects: 2195
Study 7584765 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (20 mg)
Number of subjects: 20
Study 7584765 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (40 mg)
Number of subjects: 20
Study 7584765 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine (30 mg)
Number of subjects: 20
Study 7584765 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10 mL sucrose)
Number of subjects: 20
Study 1901280 — intervention group
Group type: EXPERIMENTAL
Intervention: hMG therapy (alone or in combination with clomiphene citrate or gonadotropin‐releasing hormone agonist analog)
Number of subjects: 140
Study 1901280 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group B)
Number of subjects: 140
Study 1901280 — intervention group
Group type: EXPERIMENTAL
Intervention: hMG therapy in oligomenorrhea and PCOD patients
Number of subjects: 140
Study 1901280 — intervention group
Group type: EXPERIMENTAL
Intervention: hMG therapy in hypogonadotropic amenorrhea patients
Number of subjects: 140
Study 6129142 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenalterol (i.v. doses)
Number of subjects: 15
Study 6129142 — intervention group
Group type: COMPARATOR
Intervention: Saline (i.v. doses)
Number of subjects: 15
Study 6129142 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenalterol (inhaled doses)
Number of subjects: 15
Study 6129142 — intervention group
Group type: COMPARATOR
Intervention: Saline (inhaled doses)
Number of subjects: 15
Study 6129142 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (i.v. doses after prenalterol/saline)
Number of subjects: 15
Study 6129142 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenalterol (i.v. and inhaled doses)
Number of subjects: 15
Study 31594198 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprahyoid muscle group (SMG) - NMES with electrodes placed between the jaw and hyoid bone
Number of subjects: 38
Study 31594198 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrahyoid muscle group (IMG) - NMES with electrodes placed below the hyoid for targeted infrahyoid muscles
Number of subjects: 38
Study 30054843 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced Propofol Sedation (BPS)
Number of subjects: 186
Study 30054843 — intervention group
Group type: COMPARATOR
Intervention: Etomidate Sedation (BES)
Number of subjects: 186
Study 28598231 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg of ursolic acid once a day for 12 weeks
Number of subjects: 24
Study 25579091 — intervention group
Group type: EXPERIMENTAL
Intervention: AK106‐001616 200 mg
Number of subjects: 0
Study 25579091 — intervention group
Group type: EXPERIMENTAL
Intervention: AK106‐001616 400 mg
Number of subjects: 0
Study 25579091 — intervention group
Group type: EXPERIMENTAL
Intervention: AK106‐001616 600 mg
Number of subjects: 0
Study 25579091 — intervention group
Group type: COMPARATOR
Intervention: In vitro studies
Number of subjects: 0
Study 23665051 — intervention group
Group type: EXPERIMENTAL
Intervention: Head Down Training Group (HTG)
Number of subjects: 22
Study 23665051 — intervention group
Group type: COMPARATOR
Intervention: Upright Training Group (UTG)
Number of subjects: 22
Study 23665051 — intervention group
Group type: EXPERIMENTAL
Intervention: Head Down Tilt Posture
Number of subjects: 22